Disease-Specific Mortality and Secondary Primary Cancer in Well-Differentiated Thyroid Cancer with Type 2 Diabetes Mellitus

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Chen, Szu Tah ^a   Hsueh, Chuen ^a   Chiou, Wen Ko ^a   Lin, Jen Der ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; DIPEPTIDYL PEPTIDASE IV INHIBITOR; IODINE 131; METFORMIN; SULFONYLUREA;

ADULT; AGE; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DIFFERENTIATED THYROID CANCER; DISEASE COURSE; DISTANT METASTASIS; DRUG DOSE INCREASE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; RETROSPECTIVE STUDY; THYROIDECTOMY;

ADULT; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; NEOPLASMS, SECOND PRIMARY; RETROSPECTIVE STUDIES; TAIWAN; THYROID NEOPLASMS;

EID: 84873173103     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055179     Document Type: Article

References (24)

1. Atchison EA, Gridley G, Carreon JD, Leitzmann MF, McGlynn KA, (2011) Risk of cancer in a large cohort of U.S. veterans with diabetes. International Journal of Cancer 128: 635-643.
2. Johnson JA, Pollak M, (2010) Insulin, glucose and the increased risk of cancer in patients with type 2 diabetes. Diabetologia 53: 2086-2088.
3. Lin JD, Chao TC, Sun JH, Ho C, Weng HF, (2000) Trends in the clinical characteristics of patients with papillary thyroid carcinoma in Taiwan. Oncology 58: 280-285.
4. Davies L, Welch HG, (2006) Increasing incidence of thyroid cancer in the United States, 1973-2002. Journal of the American Medical Association 295: 2164-2167.
5. Paes JE, Hua K, Nagy R, Kloos RT, Jarjoura D, et al. (2010) The relationship between body mass index and thyroid cancer pathology features and outcomes: a clinicopathological cohort study. The Journal of Clinical Endocrinology and Metabolism 95: 4244-4250.
6. Aschebrook-Kilfoy B, Sabra MM, Brenner A, Moore SC, Ron E, et al. (2011) Diabetes and thyroid cancer risk in the National Institutes of Health-AARP Diet and Health Study. Thyroid 21: 957-963.
7. Mijović T, How J, Pakdaman M, Rochon L, Gologan O, et al. (2009) Body mass index in the evaluation of thyroid cancer risk. Thyroid 19: 467-472.
8. Lin JD, Lin KJ, Chao TC, Hseuh C, Tsang NM, (2008) Therapeutic outcome of papillary thyroid carcinoma advance than T1N0M0. Radiotherapy and Oncology 89: 97-104.
9. American Diabetes Association, (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33: S62-S69.
10. Lin JD, Weng HF, Huang MJ, Huang BY, Huang HS, et al. (1994) Thyroid cancer treated in Chang Gung Memorial Hospital (Northern Taiwan), during the period: 1979-1992: Clinical presentation, pathological finding, analysis of prognostic variables and results of treatment. Journal of Surgical Oncology 57: 252-260.
11. Delellis RA, Lloyd RV, Heitz PU, Eng C (2004) Pathology and genetics of tumors of endocrine organs. In World Health Organization of Tumours. Lyon, IARC pressed. 73-76.
12. Sobin LH, Wittekind CH, eds. (2002) International Union Against Cancer (UICC) TNM Classification of malignant tumors, 6th ed. New York, Wiley. Pp. 52-56.
13. Zhang DD, Zhou XH, Freeman DH, Freeman JL, (2002) A non-parametric method for the comparison of partial areas under ROC curves and its application to large health care data sets. Statistics in Medicine 21: 701-715.
14. Almquist M, Johansen D, Björge T, Ulmer H, Lindkvist B, et al. (2011) Metabolic factors and risk of thyroid cancer in the Metabolic syndrome and Cancer project (Me-Can). Cancer Causes and Control 22: 743-751.
15. Huang HS, Huang MJ, Huang CC, Huang BY, Lin JD, et al. (1989) HLA-A,B,C and DR antigens in Chinese with non-insulin-dependent diabetes: comparison with goitrous diabetics. Journal of the Formosan Medical Association 88: 43-47.
16. Chiou WK, Huang BY, Chou WY, Weng HF, Lin JD, (2011) Incidence of cancer in diabetic and non-diabetic hospitalized adult patients. Asian Pacific Journal of Cancer Prevention 12: 1577-1581.
17. Chang C, Lu F, Yang YC, Wu JS, Wu TJ, et al. (2000) Epidemiologic study of type 2 diabetes in Taiwan. Diabetes Research and Clinical Practice 50Suppl 2: S49-S59.
18. Schvartz C, Bonnetain F, Dabakuyo S, Gauthier M, Cueff A, et al. (2012) Impact on Overall Survival of Radioactive Iodine in Low-Risk Differentiated Thyroid Cancer Patients. The Journal of Clinical Endocrinology and Metabolism 97: 1526-1535.
19. Verlato G, Zoppini G, Bonora E, Muggeo M, (2003) Mortality from site-specific malignancies in type 2 diabetic patients from Verona. Diabetes Care 26: 1047-1051.
20. Oyer SL, Smith VA, Lentsch EJ, (2012) Reevaluating the prognostic significance of age in differentiated thyroid cancer. Otolaryngology Head and Neck Surgery 147: 221-226.
21. Jonklaas J, Nogueras-Gonzalez G, Munsell M, Litofsky D, Ain KB, et al. (2012) The impact of age and gender on papillary thyroid cancer survival. The Journal of Clinical Endocrinology and Metabolism 97: E878-887.
22. Rezzónico J, Rezzónico M, Pusiol E, Pitoia F, Niepomniszcze H, (2011) Metformin treatment for small benign thyroid nodules in patients with insulin resistance. Metabolic Syndrome and Related Disorders 9: 69-75.
23. Noto H, Goto A, Tsujimoto T, Noda M, (2012) Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis. PLoS One 7: e33411.
24. Onitil AA, Engel JM, Glurich I, Stankowski RV, Williams GM, et al. (2012) Diabetes and cancer II: role of diabetes medications and influence of shared risk factors, Cancer Causes & Control. 23: 991-1008.